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Nitric oxideRhabdomyolysis or crush syndrome is a pathology caused by muscle injury resulting in acute renal failure.
The latest data give strong evidence that this syndrome caused by accumulation of muscle breakdown
products in the blood stream is associated with oxidative stress with primary role of mitochondria. In order
to evaluate the signiﬁcance of oxidative stress under rhabdomyolysis we explored the direct effect of
myoglobin on renal tubules and isolated kidney mitochondria while measuring mitochondrial respiratory
control, production of reactive oxygen and nitrogen species and lipid peroxidation. In parallel, we evaluated
mitochondrial damage under myoglobinurea in vivo. An increase of lipid peroxidation products in kidney
mitochondria and release of cytochrome c was detected on the ﬁrst day of myoglobinuria. In mitochondria
incubated with myoglobin we detected respiratory control drop, uncoupling of oxidative phosphorylation,
an increase of lipid peroxidation products and stimulated NO synthesis. Mitochondrial pore inhibitor,
cyclosporine A, mitochondria-targeted antioxidant (SkQ1) and deferoxamine (Fe-chelator and ferryl-
myoglobin reducer) abrogated these events. Similar effects (oxidative stress and mitochondrial dysfunction)
were revealed when myoglobin was added to isolated renal tubules. Thus, rhabdomyolysis can be
considered as oxidative stress-mediated pathology with mitochondria to be the primary target and possibly
the source of reactive oxygen and nitrogen species. We speculate that rhabdomyolysis-induced kidney
damage involves direct interaction of myoglobin with mitochondria possibly resulting in iron ions release
from myoglobin's heme, which promotes the peroxidation of mitochondrial membranes. Usage of
mitochondrial permeability transition blockers, Fe-chelators or mitochondria-targeted antioxidants, may
bring salvage from this pathology.© 2009 Elsevier B.V. All rights reserved.1. IntroductionRhabdomyolysis (muscle ﬁber dissolution) is the injury-induced
pathological lysis of skeletal muscle tissue, leading to the release of
intracellular components into the extracellular ﬂuid and the circula-
tion. This process explains approximately 10 to 15% of all acute renal
failure (ARF) cases. The signiﬁcance of such pathology may be clear
from the fact that the major cause of rhabdomyolysis is the crush
factor, i.e., myolysis due to traumatic compression of muscle as a result
of accidents or disasters. There is a number of case reports on the
development of rhabdomyolysis associated with drug use such as
cocaine and ecstasy [1,2], venom poisoning [3] and alcohol abuse [4].
Interestingly, while 0.1% of all patients with coronary artery disease
using statins to lower blood cholesterol suffer from severe rhabdo-
myolysis that apparently results from altering the production of small
proteins necessary for myocyte maintenance [5], 1–5% of all statin
users complain on myalgias and muscle weakness [6].v).
ll rights reserved.Many researchers suggest the main toxic element to be myoglobin,
an 18,800 Da oxygen carrier muscle cell protein. Myoglobin is quickly
ﬁltered by the glomeruli and then resides in the tubules, where it may
cause obstruction and renal failure. The mechanisms of kidney injury
during rhabdomyolysis are still not completely understood. There is a
lack of knowledge on the participation of mitochondria as well as of
reactive oxygen and nitrogen species (ROS and RNS correspondingly)
in the development of myoglobinuric renal dysfunction, whereas its
importance in some other renal pathologies, such as kidney ischemia
and others is well established [7].
While in earlier reports it was a widely held belief that the general
cause of myoglobinuric ARF is the formation of myoglobin aggregates
and renal tubular obstruction, leading to impairment of primary urine
ﬂow and reabsorption [8–10], recent studies have shown the
development of oxidative stress under the conditions of myoglobi-
nuria, accompanied by the increased production of ROS and lipid
peroxidation [11,12]. The heme of a myoglobin molecule is thought to
play the key role in this process. In one study the oxidative damage
was caused by the direct effect of heme without releasing iron from
the heme [13]. However, the presence of hemoxygenase and
ferrochelatase in the cell [14,15] may potentially result in the
appearance of free iron in the cell with further ignition of Fenton
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accumulation in tubules, their epithelial cells show elevated expres-
sion of hemoxygenase [16] which makes such process of iron release
highly probable. We must admit that earlier reports suggested that
myoglobin may release free ferrous (Fe2+) ions, which could induce
lipid peroxidation as a result of the generation of hydroxyl radicals via
Fenton's reaction [17]. An alternative mechanism could involve the
heme moiety of myoglobin absorbed by a renal tubule cell [13, 18]. It
can be realized either through endocytotic absorption of myoglobin
[19] by the tubular cells similar to what happens with albumin [20] or
through the direct transport of heme (for example, by a speciﬁc
transporter HCP1 (heme carrier transporter) which is known to
facilitate heme transport into the cell and speciﬁcally participates in
heme capture in kidney cells [21]. Indirect evidence of the activation of
hemoxygenase after myoglobin accumulation in the tubules [16] is in
support of such speculation, however, there is no doubt that the
expression of this protein can be determined by other factors
including oxidative stress [22].
In renal tubules, oxyferrous myoglobin would undergo autooxida-
tion to the ferric form (MetMb, Fe3+), which is catalytically competent
to promote a lipid peroxidation reactions. The redox cycle occurs
between the ferric (Fe3+) and ferryl ([Fe=O]2+)myoglobin oxidation
states, and the latter can directly initiate lipid oxidation [13,18].
Until now, most researchers have proposed development of
oxidative stress during rhabdomyolysis, after detecting the presence
of lipid peroxidation products either in serum or in renal tissue. There
is a consensus that one of the basic regulators of ROS production and
cell death are mitochondria [23] but the knowledge on these
organelles functioning under myoglobinuria is still not complete.
There are limited evidences of mitochondria participation in devel-
opment of pathological processes during rhabdomyolysis [12,24,25].
Moreover, very little is known about the role of RNS in
myoglobinuria. NO is an important modulator of oxidative stress
and may be a predisposing as well as a protective factor. This issue has
taken on special signiﬁcance after the discovery of mitochondrial NO-
synthase (NOS) [26], which enables mitochondria to directly regulate
their ROS production [27].
Our studywas focused onmitochondrial functioning, development
of oxidative stress and increase of NO production in a glycerol-induced
myoglobinuria in the rat as well as the study of myoglobin effect on
isolated rat kidney mitochondria. The goal of this work was to
investigate the mitochondrial status during myoglobin-induced ARF,
to model the mitochondria dysfunction caused by myoglobin in vitro
and to study the role of mitochondrial NOS in this pathology.
2. Materials and methods
2.1. Modeling of glycerol-induced rhabdomyolysis in rat
Experiments were performed on outbred white male rats (180–
200 g) fed ad libitum. Animal protocols were approved by the
institutional review ethical committee. Rats were anesthetized with
sodium pentobarbital (50 mg/kg, i.p.). Animals in the rhabdomyolysis
group were deprived of water for approximately 36 h and then
injected with glycerol (10 ml/kg of a 50% water solution) intramus-
cular in two legs [28]. Control animals were untreated. At regular
intervals after rhabdomyolysis induction, blood samples were col-
lected for measurement of biochemical parameters and kidney were
excised for the mitochondria isolation.
2.2. Isolation of mitochondria from rat kidney
Kidney mitochondria were isolated by homogenization and
differential centrifugation in a medium containing 250 mM sucrose,
20 mMHEPES–KOH,1 mM EGTA, 0.1% BSA, pH 7.4. Mitochondria were
suspended in incubation solution (250 mM sucrose, 10 mM HEPES–KOH, 2 mM KH2PO4, 10 μM rotenone, pH7.4) and energized by adding
of 5 mMK-succinate. Total mitochondrial proteinwas determined by a
bicinchoninic acid protein assay kit (Sigma Aldrich, USA).
Mitochondrial oxygen uptake was measured with a Clark-type
oxygen electrode Oxygraph-2k (Oroborus, Paar, Austria). Reaction
components were added to the chamber containing 2 ml of incubation
buffer at 25 °C. In classical terms, one of the most important mito-
chondrial functional indices is non-phosphorylated (state 3 after ADP
supplement or state 3u after uncoupler supplement) and phosphory-
lated (state 4) respiration rate of isolatedmitochondria [29]. Proper ratio
(V3/V4), also called respiratory control index deﬁnes proton ﬂuxes
through the inner mitochondrial membrane under the state of the ATP
synthesis (V3) versus the resting state (V4). Mitochondrial uncoupling
was induced by adding 2,4-dinitrophenol (DNP) to a ﬁnal concentration
of 100 μM.Oxygen consumption rate for state 3 and 4was calculated per
amount of mitochondrial protein in the sample.
2.3. Measurement of MDA products and nitric oxide in serum and
mitochondria of rat kidney
Malonic dialdehyde was determined in the sample by thiobarbi-
turic acid assay according to the method of [30] with minor
modiﬁcation. Each sample was mixed with 0.8% thiobarbituric acid
and 1% H3PO4 in the ratio 0.9:1.0:3.0. The mixture was boiled for
45 min and centrifuged after cooling at 15,000 g for 10 min.
Absorbance of the resulting supernatant at 532 nm was measured
by a Hitachi 557 spectrophotometer. 1,3,3-tetraetoxipropan (Sigma,
USA) was used as a standard solution.
Nitric oxide was measured by colorimetric method of Griess
(Griess reagent, Sigma-Aldridge, USA). To remove protein the samples
were mixed with an equal volume of icy methanol, incubated for
5 min at 4 °C and centrifuged at 20,000 g for 10 min. The resulting
supernatant was combined with an equal volume of Griess reagent
and incubated for 30 min at 4 °C. The absorbance at 540 nm was
measured using a plate reader (LabSystems Multiscan).
2.4. Incubation of mitochondria with myoglobin in vitro
Mitochondria were diluted to a ﬁnal concentration of 4 mg/ml
with the incubation buffer containing 250 mM sucrose, 10 mMHEPES,
1 mM EGTA, 0.1% BSA, pH 7.4. 5 mM K-succinate and 10 μM rotenone
were added to initiate the respiration. Myoglobin was added to the
sample to ﬁnal concentrations of 50, 100, 500 μM, accordingly. The
control sample was supplemented either with the same amount of
BSA or the incubation medium. Samples were incubated for 1 h at
room temperature with gentle shaking then some aliquots of
mitochondria were used for oxygen consumption measurements
and another were centrifuged (10,500 g) for 10 min. The pellet was
suspended in 1.15% KCl with 10 mM EGTA and was used for MDA
measurements. Supernatant was used for nitrite determination.
2.5. Western blot analysis
Samples of serum or mitochondria, normalized for total protein
content (50 mg/lane), were separated by Tris–tricine electrophoresis
into 16.5% PAAG and transferred onto a PVDF membrane (Amersham
Pharmacia Biotech, Rainham, UK). Membranes were blocked with 3%
(wt/vol) non-fat milk in PBS with 0.1% (v/v) Tween 20, subsequently
incubated with primary antibodies: mouse monoclonal anti-cyto-
chrome c 1:1000 (BD Biosciences Pharmingen, USA), mouse mono-
clonal anti-porin 1:1000 (BD Biosciences Pharmingen, USA) or rabbit
monoclonal myoglobin 1:500 (Santa Cruz, USA) and stained with
anti-mouse IgG or anti-rabbit IgG conjugated with horseradish
peroxidase (Calbiochem, USA). The detection was made using ECL
Western blotting kit (Amersham Pharmacia Biotech, Rainham, UK).
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Bethesda, MD, USA) after scanning.2.6. Measurement of mitochondria membrane potential and ROS
production in isolating tubules
Kidneys of 3–7 days old rats were excised and dissociatedwith 0.1%
collagenase solution (20 min at 37 °C). Large fragments of tissue were
removed, and tubules were precipitated by gentle centrifugation
(50 g) for 3 min. The pellet was suspended in DMEM/F-12 medium
without bicarbonate supplemented with 20 mM HEPES. All further
steps were done at 37 °C.
The myoglobin solution was added to the tubules suspension to
ﬁnal concentration of 500 μM and incubated for 1 h. Then tubules
were washed out of myoglobin and incubated with ﬂuorescent probes
TMRE (200 nM) and 2′,7′-dichlorodihydroﬂuorescein diacetate (DCF,
10 μM, Invitrogen, USA). Renal tubules were imaged with an LSM510
inverted confocal microscope (Carl Zeiss Inc., Jena, Germany) in a
multi-channel mode as appropriate for the dyes loaded. Analysis of
ﬂuorochrome incorporation was performed in glass-bottom dishes
with the excitation at 488 nm (for DCF) and 543 nm (for TMRE), and
emission collected at 500–530 nm and N560 nm, respectively. To
minimize the contribution of photo-induced mitochondria/cell
damage in the relative ﬂuorescence intensities we analyzed images
used by averaging ﬁrst four scans only. Images were processed by
ImageJ software (NIH, Bethesda, MD, USA).2.7. Statistics
All the experiments were performed more than in triplicate. All
data are mean±SEM. Comparisons within groups were made by
Student t test, and P value less than 0.05 was taken to indicate
statistical signiﬁcance.Fig. 1. ARF development and the damage of kidney mitochondria in rhabdomyolytic rats. Th
ARF development on the ﬁrst days after rhabdomyolysis induction. Appearance of myoglob
kidney homogenate with anti Mb antibodies where lane 1, rat skeletal muscle; lane 2, co
correspondingly). Cytochrome c appears in the blood (D) western blotting of blood serum w
48 h after induction of rhabdomyolysis correspondingly) with a corresponding loss of cytoc
control kidney mitochondria. (F) The same samples as in E with anti-VDAC antibodies.3. Results
3.1. Mitochondrial damage in myoglobin-induced ARF
This study of ARF development under rhabdomyolysis demon-
strates that the activities of principal enzyme-reporters of the tissue
damage (such as lactate dehydrogenase (LDH) and alanine amino-
transferase (ALT)) increased greatly in the blood within the ﬁrst
2 days (Fig. 1B). A basic index of severe ARF development was the
increase in the blood of nitrogen metabolism products (urea and
creatinine) in the blood, which reached its maximum at 1–2 days (Fig.
1A). Further, most parameters returned to a normal level that allows
suggesting functional recovery of kidneys.
We found that myoglobin deposits in the kidney tubules become
already detectable during very ﬁrst hours after rhabdomyolysis
induction (Fig. 1C). In control kidney, myoglobin was not detected
(Fig. 1С). Myoglobin appeared in the renal tissue 3 h after glycerol
injection, and its maximal concentration was observed after 15 h, and
went down to a non-detectible level after 24 h. The latter may be due
to the possibility that the protein moiety of myoglobin molecule was
at least partially degraded, resulting in the failure of speciﬁc
antibodies to detect the antigen. Also myoglobin could be rapidly
excreted in the urine already at ﬁrst day of rhabdomyolysis.
We used the release of cytochrome c from kidney mitochondria as
a marker of their damage [31]. There is evidence that at cell apoptotic
death, cytochrome c not only is released from mitochondria into the
cytoplasm, but also appears in the extracellular space. It seems that
blood plasma cytochrome c level reﬂects the degree of tissue injury. In
fact, we revealed that cytochrome c was detected in the blood of
rhabdomyolytic rats (Fig. 1D). This demonstrated the extensive
damage of renal cells and the induction of their apoptotic or necrotic
death. Cytochrome c was not found in control serum.
More conclusive proof of apoptotic launching and mitochondria
injury in renal cells was obtained by western blotting of mitochondria
isolated from kidneys on different periods of rhabdomyolysis. Wee rise of blood urea and creatinine level (A), and ALT and LDH activity (B) are indices of
in in the blood correlates with its accumulation in the kidney (C) western blotting of
ntrol kidney; lanes 3–5, the kidney 4, 15 and 24 h after induction of rhabdomyolysis
ith anti-cytochrome c antibodies where lane 1, control serum; lanes 2–5, 5, 16, 24 and
hrome c in isolated kidney mitochondria (E, lanes 1–4, 4, 16, 24, and 48 h, and lane 5,
Fig. 2. Dysfunction of kidney mitochondria and lipid peroxidation during rhabdomyo-
lysis. Oxygen consumption rate in state IV (A), respiratory control (B) and concentration
of MDA products (C) in mitochondria isolated from kidney of rats at various times after
induction of rhabdomyolysis are shown.
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decreased and maximum of cytochrome c release was observed at
4 h after rhabdomyolysis induction.Table 1
The inﬂuence of incubation with myoglobin on functional characteristics of renal
mitochondria: the respiration rates in state 3 (V3s) and 4 (V4u) and the respiratory control.
Sample V4S (nmol О2
min−1 mg−1)
V3U (nmol О2
min−1 mg−1)
Respiratory
control
Control 11.5±2.1 55.1±5.3 4.8±0.6
100 μM Mb 22.7±1.7 54.5±4.2 2.4±0.3
500 μM Mb 32.5±5.4 51.0±3.6 1.6±0.6
100 μM Mb+2 mM DFO 16.6±1.2 53.2±6.8 3.2±0.2
500 μM Mb+100 nM SkQ1 38.6±4.6 54.1±6.8 1.4±0.2
100 μM Mb+100 nМ CsA 12.3±2.8 52.9±10.3 4.3±0.5
100 μM BSA 12.6±1.3 52.1±9.1 4.1±0.3
500 μM BSA 11.85±1.7 54.3±11.3 4.5±0.1
The effects of mitochondria-targeted antioxidant SkQ1, iron ions chelator DFO and PTP
inhibitor cyclosporin A are presented.3.2. Oxidative stress and dysfunction of mitochondria in
rhabdomyolytic rats
We analyzed basic functional parameters of mitochondria isolated
from kidney at different periods after rhabdomyolysis induction. In a
ﬁrst turn, the oxygen consumption rates with succinate in state 3 and
4 (V3U and V4S) and MDA levels were measured and V3U/V4S ratio was
determined in mitochondria. We revealed an essential increase of
MDA level in mitochondria on the very ﬁrst day of myoglobinuria
(Fig. 2A), which demonstrated that a signiﬁcant oxidative stress
evolves, leading to a lipid peroxidation in mitochondria. The greatest
rise was observed after 4 h when MDA level rose twice as compared
with control values. After 15 h of rhabdomyolysis, MDA concentration
in mitochondria stabilized and later on the same day began to drop.
Twenty-four hours after glycerol injection the oxygen consump-
tion rate (at state 4) increased (Fig. 2B). This indirectly indicates some
loss of a coupling between oxidation and phosphorylation in
mitochondria, possibly due to a change of permeability in the inner
mitochondrial membrane to ions. Although the state 3 respiration rate
(with the uncoupler) did not changemuch (data not shown), the ratio
V3U/V4S in rhabdomyolytic mitochondria was signiﬁcantly diminished.3.3. In vitro model of myoglobin inﬂuence on mitochondria functioning
For a more comprehensive study of myoglobin effect on mitochon-
dria, we used an in vitro model, where myoglobin directly interacts
with isolated renal mitochondria. Apart from the consideration that
the renal tubule cells intake mainly heme or heme iron [12], the
probability of absorption by the cells of intact myoglobin molecules
from tubules lumen cannot be ruled out. Such transport is typical for
most proteins as they are ﬁltering into primary urine from blood
plasma following by reabsorption in renal tubules [32].
To study the direct effect of myoglobin on kidney mitochondria,
themitochondrial suspensionwas supplementedwith a commercially
available form of myoglobin, metmyoglobin (Fe3+). It is known that
mitochondria can reduce the iron in metmyoglobin molecule (Fe3+)
to a ferrous form (Fe2+) using succinate as a respiratory substrate [33],
resulting in the presence of both forms of myoglobin in the incubation
medium. Therefore, this ability of mitochondria has no need to
artiﬁcially reducemyoglobin's heme, and apparently, the systemmore
closely corresponds to the situation in kidney in vivo, where both
forms of myoglobin are present.
When studying the interaction of myoglobin with mitochondria in
vitro we analyzed the mitochondrial oxygen consumption rate after
incubation with myoglobin and the behavior of markers of oxidative
and nitrosyl stress, because these parameters were found to change in
vivo. In a control system, we substituted myoglobin for appropriate
concentration of BSA. Data on mitochondria function impairment are
presented in Table 1.
We found that mitochondrial respiration rate in state 4 increases
twice and to about three-fold as referred to control values at myoglobin
concentrations 100 and 500 μMcorrespondingly 1 h after preincubation
withmyoglobin at room temperature. IncubationwithBSAdid not affect
the respiration rate, showing that the previous effect was not due to a
change of oncotic pressure caused by the presence of protein in the
incubation medium. The uncoupling respiration rate (state 3u) almost
did not change during incubation with either myoglobin or BSA, which
correlates with our data for function of mitochondria isolated from the
kidneys of rats suffering myoglobinuria. The low respiratory control of
mitochondria incubated with myoglobin may be explained by that on
average the population of isolated mitochondria is less coupled and
apparently there is a link between relative uncoupling and the presence
of peroxidated lipids, suggesting a lipid peroxide-induced distortion of
the ion permeability of the inner mitochondrial membrane. Further
experiments revealed that 100 nM cyclosporine A (CsA) protects from
the myoglobin-induced drop of the respiratory control (Table 1). These
results can be interpreted in theway thatMb causes the induction of the
permeability transition in some part of the population of isolated
mitochondria (potentially resulting in the absence of the membrane
potential in these mitochondria and maximal activation of their
respiration), which is misleading by giving an average lowering of the
respiratory control with the tentative wrong interpretation of mito-
chondrial uncoupling.
Fig. 3. Oxidative stress and NO production in rat kidney mitochondria incubated with
myoglobin. Generation of MDA products (A) and nitrite (B) in mitochondria, incubated
with different concentrations of myoglobin supplemented with: 5 mM of NOS substrate
L-arginine; 2 mM of iron chelator, DFO; 100 nM of PTP inhibitor, CsA; 100 nM
mitochondria-targeted antioxidant SkQ1, and 5 mM of NOS inhibitor L-NAME.
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of 2 mM chelator of iron ions, deferoxamine (DFO) showed that this
chelating signiﬁcantly althoughnot fully restored the respiratory control
value (Table 1).When comparedwith the data on the prevention of the
myoglobin-induced changes of mitochondrial functional parameters,
these data show that chelation of iron ions does not prevent the
mitochondrial permeability transition caused by myoglobin supple-
ment. The administration of mitochondria-targeted antioxidant SkQ1
also did not improve the functional characteristics of uncoupled mito-
chondria (Table 1). Both DFO and antioxidant greatly reduced the ge-
neration of MDA products and generation of nitrite as well (see below).
However we cannot exclude the possibility that the inhibitory
effect of DFO is due to its ability to reduce ferryl myoglobin [34,35]
which is known to promote lipid peroxidation. We tried to add
reducing equivalents (i.e. ascorbate, not shown) and observed lower
amount of MDA products in isolated mitochondria after incubation
with myoglobin. However we cannot exclude that ascorbate can
signiﬁcantly shift the entire redox state of mitochondrial matrix
towards more reduced state thus increasing the antioxidative capacity
of the system. Unfortunately, all possible experimental designs cannot
provide the clean discrimination between these two possibilities.
3.4. Oxidative stress and NO production in mitochondria caused by
myoglobin
The suggestion that the failure of the permeability barrier by the
inner mitochondrial membrane after myoglobin exposure is due to
lipid peroxidation of mitochondrial membranes was conﬁrmed by the
data that MDA products in mitochondria are doubled during
incubation with 100 μM myoglobin for 1 h and almost tripled with
500 μM (Fig. 3A). Simultaneous incubation with both myoglobin and
100 nM CsA reduced the MDA production markedly, however, the
control values were not achieved. This implied that myoglobin-
induced PTP induction is at least partially responsible for oxidative
stress and lipid peroxidation. Essential antioxidative effect was
noticed for DFO, although again, as in case of cyclosporine A, full
recovery was not observed (Fig. 3). The beneﬁcial effect of SkQ1 was
modest but signiﬁcant (Fig. 3). It is reported that this new
mitochondria-targeted antioxidant accumulates in mitochondria and
efﬁciently prevents ROS production and mitochondria dysfunction in
different types of oxidative stress [36–43]. Thus, it looks probable, that
free iron released from the myoglobin's heme signiﬁcantly contrib-
uted to the overall damaging effect of myoglobin on mitochondria,
inducing lipid peroxidation, apparently mediated by a Fenton
reaction. Mitochondria-targeted antioxidants apparently replenished
mitochondrial antioxidative defense and signiﬁcantly hampered
deleterious Fe-mediated oxidative lipid damage somehow going
with the involvement of the mitochondrial permeability transition.
Finally, we studied the change of NO production during myoglobin-
induced oxidative damage of mitochondria. The prerequisites for such a
studywere our ﬁndings of the rise of a nitrite (product of NO oxidation)
level in the bloodplasmaof rhabdomyolytic rats. On the seconddayafter
onset of myoglobinuria, the concentration of nitrite in serum was
12.0±1.5 μM,whereas it was 4.5±0.5 μM in the control sample. In vitro
model also revealed the growth of the nitrite concentration in the
incubation medium of isolated mitochondria (Fig. 3B). Although the
increase of nitrite level at 100 μM myoglobin was not signiﬁcant, it
reached almost 7-fold at 500 μM of myoglobin referred to a level
observed in the control sample. We proposed that myoglobin activates
the mitochondrial NOS, resulting in the rise of NO level and received
indirect support of this idea from the fact that the supplement of the
system with NOS substrate L-arginine (5 mM) signiﬁcantly enhanced
the effect of myoglobin alone (Fig. 3B). Conversely, NOS inhibitor
L-nitroarginine decreased the nitrite concentration to the control level.
DFO reduced the myoglobin-induced growth of nitrite concentration at
such conditions as well. The tentative explanation of these data is thatmyoglobin supplement causes the activation of ROS production
(possibly superoxide because it may be scavenged by hydrophobic
mitochondria-targeted antioxidant SkQ)which in turn activates NOS. In
this case, the rise of MDA products (possibly originating from the
elevated ROS level) goes in parallel with the rise of nitrite (apparently
originating from activated NOS).
3.5. Oxidative stress and dysfunction of renal tubules mitochondria
induced by myoglobin
Apparent signs of mitochondrial alterations induced by myoglobin
found in isolated mitochondria were conﬁrmed by using confocal
microscopy of isolated renal tubules. The incubation of tubules with
100 μM myoglobin resulted in a rise of DCF ﬂuorescence signal in
tubules cells (Fig. 4A,B) pointing to the induced increase of ROS
production in these cells. At the same time, we revealed a signiﬁcant
reduction of TMRE ﬂuorescence signal, pointing to the drop of the
mitochondrial membrane potential (Fig. 4C,D). These facts support
the conclusion that myoglobin causes the distortion of barrier
function of the inner mitochondria membrane and provokes the
development of oxidative stress. Interestingly, the simultaneous
staining of tubules with DCF and TMRE revealed good colocalization
of these probes, which points to dominating generation of ROS in
mitochondria.
4. Discussion
In a given study, we pursued a goal to ascertain the link between
provoked ARF development and changes in renal mitochondria
Fig. 4. ROS generation and disruption of mitochondrial potential in renal tubules cells
incubated with myoglobin. Incubation of renal tubules with 500 μM myoglobin for 1 h
causes signiﬁcant increase of ROS production (B) and the drop of the membrane
potential as indicated by the rise of DCF (B) and TMRE (D) ﬂuorescence. (A, C) Control
renal tubules stained with DCF and TMRM correspondingly. Diagrams indicate average
ﬂuorescence intensity through 10 confocal images in each sample. Bar 100 μm.
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pathology proceeds with peroxidation of mitochondrial lipids point-
ing to the involvement of the oxidative stress. It appears conceivable
that such mitochondrial damage is one of the principal causes of
kidney dysfunction. The dynamics after the crush onset show that
already during the ﬁrst hours after muscle degradation myoglobin
becomes detectable in renal tubules, and kidney mitochondria
malfunctioning can be observed. Induced pathological changes in
kidney resulting in the loss of mitochondrial cytochrome c and its
appearance in urine, possibly associated with the induction of
mitochondrial permeability transition and apoptotic challenge were
indicated in earliest reports [31,44].
It is possible that these changeswere accompanied bydevelopment
of oxidative stress, peroxidation of mitochondrial membranes and
uncoupling of oxidative phosphorylation inmitochondria. Stimulation
of these processes was proved by accumulation of MDA products in
kidney mitochondria and falling of the respiratory control within very
ﬁrst hours after the induction of rhabdomyolysis. Kidneymalfunction-
ing, increase of uremia and azotemia occur either simultaneously with
these events or with some delay (Fig. 1), and is likely a consequence of
mitochondrial dysfunction and oxidative stress.Such set of abnormalities is typical for ARF provoked by ischemia/
reperfusion [7]. The mitochondrial dysfunction and hyperproduction
of ROS tightly correlate with ischemic damage often resulting in a
kidney cells death and further ARF. However, apparently under
myoglobinuria another scenario may come into play also with the
involvement of oxidative stress. In this case, redox-modiﬁed myoglo-
bin and/or iron released from its heme are most likely the primary
sources of radicals, and the damage of mitochondria could be a
secondary process [13,18]. According to this scenario, mitochondria
can not only transmit but also amplify the transmission of oxidative
damage [45]. But the detailed mechanism of myoglobin inﬂuence on
mitochondria remained unresolved. In two studies, renal tubules [24]
or cultivated cells [25] were exposed to myoglobin, and mitochondrial
functioning was evaluated through indirect effect of mitochondrial
inhibitors on MDA products formation and viability of cells. We still
cannot exclude the possibility that the primary target for myoglobin
being in a native or modiﬁed form and for iron released from its
heme may be upstream of mitochondria with further signaling to
mitochondria.
Apparently, in such complex system as a cell, exogenousmyoglobin
may lead to a change in different pathways and mitochondrial
contribution might be signiﬁcantly obscured. No doubt that cellular
model being more difﬁcult in interpretation still is more advanced
being more close to in vivo situation but more simpliﬁed model of
direct effect of myoglobin on mitochondria was needed. We were
aware of that quite often the data received in vitro (with isolated
mitochondria) and in situ (with isolated cells) are conﬂicting.
Particularly in the above mentioned study, when using cells, the
inhibition of a respiratory chain by rotenone led to increase of MDA
products generation, while antimycin A caused their reduction,
although in both cases the death of kidney cells virtually did not
change. However, it is known that these inhibitors have the opposite
effects on isolated mitochondria, for example rotenone decreases ROS
generation by blocking formation of superoxide in the complex I of
respiratory chain [46] and antimycin increases this generation by
blocking a respiratory chain at Q-cycle level [46]. On the other hand,
some effectors (i.e. hypoxia/reoxygenation) tested in isolated mito-
chondria [47–49] demonstrate the responses similar to those
observed in the cells with some peculiar distinctions. In addition, it
has been shown that myoglobin in its native form can be uptaken by
the renal cells by endocytosis [19] thus getting a direct access to
intracellular mitochondria. Considering this, the study of interaction
of myoglobin with isolating mitochondria made good sense.
In fact, using isolated mitochondria we found that myoglobin
induces the same changes in mitochondrial functions as was found for
myoglobinuria in vivo. The rise of respiration rate in state 4 and the
drop of respiratory control were arguments in proof of mitochondrial
uncoupling and accumulation of MDA directly pointed to that
deleterious effect of myoglobin apparently involved lipid peroxida-
tion. Also, the development of oxidative stress and the loss of
mitochondria potential in tubule cells loaded with myoglobin were
observed as well. The key role in mitochondrial lipid peroxidation
probably belongs to iron ions released from themyoglobin heme since
this process was sensitive to Fe-chelator DFO (Fig. 3A). The lack of
mitigating effect of DFO and antioxidant SkQ1 on the mitochondrial
coupling after incubation with myoglobin was quite unexpected. Both
compounds causing elevation of MDA products apparently via
induced lipid peroxidation did not restore the respiration control,
decreased duringmyoglobin action. Due to the ability of DFO to reduce
ferryl myoglobin, we still cannot exclude the possibility that since
lipid peroxidation does occur in this system, this might suggest that
ferryl myoglobin is generated and the presence of DFO lowers the
toxicity of myoglobin through its reducing capacity. Unfortunately, the
usage of other reducing agents (such as ascorbate which lowered lipid
peroxidation) seems to be not optimal since we cannot exclude the
general shift of the redox state in the entire system (mitochondrial
802 E.Y. Plotnikov et al. / Biochimica et Biophysica Acta 1792 (2009) 796–803matrix) towards more reduced onewhichmay affect the antioxidative
capacity of the system.
We found that PTP inhibitor, cyclosporine A, prevents myoglobin-
induced mitochondrial damage. It not only restored the respiratory
control, being felt during incubationwith myoglobin, but also reduced
the accumulation of MDA products. Based on these facts one can
suppose two tentative pathways of myoglobin effect on mitochondria.
From one side, it could promote the lipid peroxidation and on the
other hand, it could induce mitochondrial permeability transition and
these processes within certain limits apparently proceed quite
independently. On the other hand, the inhibition of PTP partially
reduced the lipid peroxidation, proving the pore to be one of the key
players in myoglobin-mediated oxidative stress in mitochondria. But
based on the absence of restoring effects of DFO and antioxidant SkQ1
on the mitochondrial coupling we conclude that suppression of lipid
peroxidation cannot prevent the mitochondria dysfunction.
Another important ﬁnding was the demonstration of NO synthesis
activation in mitochondria exposed to myoglobin. NO participation in
regulation of damage during rhabdomyolysis was suggested in earlier
reports [13,18] with later evidence of positive inﬂuence of NO-donors
on kidney functional recovery after rhabdomyolysis [50]. In our
experiments, we revealed the increase of nitrite level in the blood of
animals after rhabdomyolysis with the non-speciﬁc inhibitor of NOS,
L-NAME being protective from this rise which was explained by the
enhanced generation of NO by NOS under rhabdomyolysis. NO is
known to be an important regulator of mitochondria functions, with
respiratory components as primary targets possibly attenuating ROS
generation [27]. Earlier we demonstrated the rise of NO synthesis in
mitochondria of the kidney exposed to ischemia/reperfusion [7].
Since in this study the nitrite abundance was blunted by DFO and
speciﬁc mitochondria-targeted antioxidant SkQ1, we can speculate
that myoglobin itself, iron ions released from it and induced ROS
generation as well activate mitochondrial NOS.
In conclusion, we found mitochondria to play an important role in
the development of kidney dysfunction under rhabdomyolysis with
the involvement of ROS and RNS. In this case, mitochondria are not
only the target for myoglobin and iron ions released from it but also a
transmitter and induced source of these reactive molecules. All of
these factors affect mitochondrial respiration, which apparently
contributes greatly to the kidney pathological changes, possibly
resulting in kidney cells death and ARF development. Lipid peroxida-
tion of mitochondrial membranes may become a crucial factor of
myoglobin-induced damage of mitochondria, which can be developed
after direct interaction of mitochondria with myoglobin. Participation
of mitochondrial NOS in these processes opens new horizons in the
system of renal cell interactions with myoglobin, which needs further
investigation.
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